Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023

SELL
$160.2 - $179.79 $3.6 Million - $4.05 Million
-22,500 Reduced 60.0%
15,000 $2.65 Million
Q3 2022

Nov 04, 2022

BUY
$161.33 - $179.52 $2.02 Million - $2.24 Million
12,500 Added 50.0%
37,500 $6.13 Million
Q2 2022

Aug 10, 2022

SELL
$168.19 - $186.01 $1.68 Million - $1.86 Million
-10,000 Reduced 28.57%
25,000 $4.44 Million
Q1 2022

May 09, 2022

BUY
$158.14 - $179.59 $790,699 - $897,950
5,000 Added 16.67%
35,000 $6.2 Million
Q4 2021

Feb 08, 2022

SELL
$155.93 - $173.01 $6.24 Million - $6.92 Million
-40,000 Reduced 57.14%
30,000 $5.13 Million
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $2.42 Million - $2.69 Million
15,000 Added 27.27%
70,000 $11.3 Million
Q2 2021

Aug 10, 2021

BUY
$159.48 - $171.07 $3.19 Million - $3.42 Million
20,000 Added 57.14%
55,000 $9.06 Million
Q1 2021

May 12, 2021

SELL
$153.07 - $170.48 $4.59 Million - $5.11 Million
-30,000 Reduced 46.15%
35,000 $5.75 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $685,550 - $786,900
5,000 Added 8.33%
65,000 $10.2 Million
Q3 2020

Nov 13, 2020

BUY
$140.38 - $153.83 $4.21 Million - $4.61 Million
30,000 Added 100.0%
60,000 $8.93 Million
Q2 2020

Aug 14, 2020

BUY
$128.81 - $155.51 $3.86 Million - $4.67 Million
30,000 New
30,000 $4.22 Million
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $3.89 Million - $5.39 Million
-35,000 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$127.5 - $146.44 $4.46 Million - $5.13 Million
35,000 New
35,000 $5.11 Million
Q1 2018

May 08, 2018

SELL
$125.1 - $148.14 $3.75 Million - $4.44 Million
-30,000 Closed
0 $0
Q4 2017

Feb 08, 2018

BUY
$131.22 - $143.62 $3.94 Million - $4.31 Million
30,000 New
30,000 $4.19 Million
Q3 2017

Nov 08, 2017

BUY
$129.47 - $135.38 $0 - $0
0
0 $0

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Sivik Global Healthcare LLC Portfolio

Follow Sivik Global Healthcare LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivik Global Healthcare LLC with notifications on news.